H.R. 1973 (110th): Vaccine Safety and Public Confidence Assurance Act of 2007

Introduced:
Apr 19, 2007 (110th Congress, 2007–2009)
Status:
Died (Referred to Committee)
Sponsor
David “Dave” Weldon Jr.
Representative for Florida's 15th congressional district
Party
Republican
Text
Read Text »
Last Updated
Apr 19, 2007
Length
30 pages
Related Bills
H.R. 5887 (109th) was a previous version of this bill.

Referred to Committee
Last Action: Jul 25, 2006

 
Status

This bill was introduced on April 19, 2007, in a previous session of Congress, but was not enacted.

Progress
Introduced Apr 19, 2007
Referred to Committee Apr 19, 2007
 
Full Title

To improve vaccine safety research, and for other purposes.

Summary

No summaries available.

Cosponsors
9 cosponsors (5R, 4D) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


4/19/2007--Introduced.
Vaccine Safety and Public Confidence Assurance Act of 2007 - Amends the Public Health Service Act to establish the Agency for Vaccine Safety Evaluation in the Office of the Secretary of Health and Human Services. Requires the Director for Vaccine Safety Evaluation to:
(1) conduct or support safety research and monitor licensed vaccines;
(2) develop a vaccine safety research agenda;
(3) evaluate means to promote compliance with federal adverse reaction reporting requirements;
(4) provide a clearinghouse for vaccine studies;
(5) ensure that functions relating to vaccine monitoring or research on adverse reactions are not carried out by anyone with a conflict of interest;
(6) oversee the Vaccine Safety Datalink Project; and
(7) resolve U.S. conflicts of interest related to international agreements, partnerships, and activities.
Allows the Director to establish a program of awarding fellowships for research on vaccine safety.
Requires the Commissioner of Food and Drugs to provide the Director, upon request, with complete access to all vaccine-related information submitted to the Food and Drug Administration (FDA) by vaccine manufacturers.
Requires the Director to require vaccine manufacturers to: (1) provide for postmarketing surveillance and clinical testing for any acute or chronic adverse reactions associated with the vaccine; and (2) register in a qualified public registry each clinical trial conducted or supported by the manufacturer with respect to the vaccine.
Transfers to the Agency Centers for Disease Control and Prevention (CDC) responsibilities for the Vaccine Safety Datalink Project, the Clinical Immunization Safety Assessment Centers, or any other post-licensure vaccine safety monitoring activities.
Requires the Secretary to establish an advisory council in the Agency.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1973 (110th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus